arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

NeoGenomics, Inc.

NEO Health Care Precision Instruments
$17.19
▼ -1.1% Today
as of Sep 4, 16:52 ET
Last 30 days +29.70% Jul 28 → Sep 04
$12.98 $14.50 $16.02 $17.54 $19.06 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$17.20
High
$17.47
Low
$16.86
Volume
$996,821
Avg Vol
$2M
Mkt Cap
$2.0B
P/E (TTM)
—
Beta
—
52w High
$19.76
52w Low
$7.07
Div Yield
—
Shares Out
$128M

Recent Press Releases & News last 60 days · 25 items

Sep 1 · 11:05 PR Business Wire
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Aug 27 · 19:10 MT Newswires
Update: NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage
Aug 27 · 15:45 Barchart
NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$7.07
$20
80% of range
Avg surprise (last 2)
+20.8%
Avg reaction (last 1)
-34.0%
0% positive
Latest IV / EM
57%
EM ±8.9% · $17 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.61$-0.35$-0.08$0.18$0.44 Actual $-0.08Est $-0.11Actual $-0.06Est $-0.07 Mar/2025Jun/2025
Revenue vs Net Income Revenue Net income
$-45M$19M$83M$148M$212M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jul 29, 2025Jun/2025 $-0.06 $-0.07 +14.3% — — earnings
Tue Apr 29, 2025Mar/2025 $-0.08 $-0.11 +27.3% — -34.0% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$202M$187M—$188M$181M$168M—$168M
Cost of revenue$110M$106M—$107M$104M$95M—$93M
Gross profit$92M$81M—$80M$77M$73M—$75M
Operating income$-10M$-18M—$-27M$-48M$-28M—$-21M
Net income$2M$-17M—$-27M$-45M$-26M—$-18M
EPS (diluted)————————

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$146M$146M$160M$164M$155M$346M$367M$362M
Inventory$27M$30M$29M$28M$34M$30M$27M$24M
Total current assets$381M$374M$376M$382M$393M$574M$596M$590M
Total assets$1.35B$1.35B$1.36B$1.37B$1.39B$1.60B$1.64B$1.64B
Long-term debt$374M—$342M—————
Total liabilities$567M$518M$523M$536M$540M$713M$736M$733M
Total equity$786M$829M$837M$838M$854M$888M$902M$908M

Implied volatility — last 90 days

50%148%247%345%443% Jun 07 — IV 88% · EM ±12.2%Jun 08 — IV 73% · EM ±9.6%Jun 10 — IV 113% · EM ±13.3%Jun 11 — IV 75% · EM ±8.3%Jun 16 — IV 444% · EM ±26.2%Jun 19 — IV 90% · EM ±20.0%Jun 22 — IV 73% · EM ±15.2%Jun 23 — IV 92% · EM ±18.7%Jun 24 — IV 81% · EM ±16.3%Jun 25 — IV 103% · EM ±20.2%Jun 26 — IV 88% · EM ±16.8%Jun 29 — IV 61% · EM ±10.9%Jun 30 — IV 64% · EM ±11.0%Jul 01 — IV 73% · EM ±12.2%Jul 02 — IV 63% · EM ±10.2%Jul 03 — IV 65% · EM ±10.2%Jul 06 — IV 74% · EM ±10.2%Jul 07 — IV 80% · EM ±10.5%Jul 08 — IV 91% · EM ±11.4%Jul 09 — IV 68% · EM ±8.0%Jul 13 — IV 81% · EM ±6.7%Jul 14 — IV 131% · EM ±9.5%Jul 15 — IV 165% · EM ±9.7%Jul 16 — IV 218% · EM ±9.1%Jul 20 — IV 93% · EM ±21.9%Jul 21 — IV 86% · EM ±20.1%Jul 22 — IV 90% · EM ±20.7%Jul 23 — IV 96% · EM ±21.6%Jul 24 — IV 87% · EM ±19.3%Jul 27 — IV 99% · EM ±20.7%Jul 28 — IV 84% · EM ±17.3%Jul 29 — IV 78% · EM ±15.7%Jul 30 — IV 59% · EM ±11.5%Jul 31 — IV 65% · EM ±12.4%Aug 03 — IV 74% · EM ±13.1%Aug 04 — IV 59% · EM ±10.1%Aug 05 — IV 78% · EM ±13.0%Aug 06 — IV 92% · EM ±14.9%Aug 07 — IV 50% · EM ±7.8%Aug 10 — IV 126% · EM ±17.4%Aug 11 — IV 52% · EM ±6.8%Aug 12 — IV 126% · EM ±15.8%Aug 13 — IV 54% · EM ±6.4%Aug 14 — IV 57% · EM ±6.3%Aug 17 — IV 85% · EM ±7.1%Aug 18 — IV 61% · EM ±4.4%Aug 19 — IV 129% · EM ±7.6%Aug 20 — IV 189% · EM ±7.9%Aug 24 — IV 79% · EM ±16.6%Aug 25 — IV 62% · EM ±12.7%Aug 26 — IV 88% · EM ±17.6%Aug 27 — IV 54% · EM ±10.6%Aug 28 — IV 56% · EM ±10.8%Aug 31 — IV 73% · EM ±13.0%Sep 01 — IV 65% · EM ±11.2%Sep 02 — IV 101% · EM ±16.8%Sep 03 — IV 65% · EM ±10.5%Sep 04 — IV 57% · EM ±8.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in